MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Perlegen Sciences announced today the successful recruitment of three senior professionals to help the company prepare for several key landmark drug response studies. Patient identification and DNA collection is already underway for the initial study, with additional sample collections scheduled to commence before year end.
